Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell

FASEB Journal

Volumn 27, Issue 12, 2013, Pages 4890-4898

  Kuliawat, Regina ^b   Klein, Laura ^a   Gong, Zhenwei ^a   Nicoletta Gentile, Marianna ^a   Nemkal, Anjana ^a   Cui, Lingguang ^a   Bastie, Claire ^c,d   Su, Kai ^a   Huffman, Derek ^c   Surana, Manju ^c   Barzilai, Nir ^c   Fleischer, Norman ^c   Muzumdar, Radhika ^a  

^a CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^b Department of Developmental and Molecular Biology ^*  (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Diabetes; Hyperglycemic clamps; Pancreatic islets

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); HUMANIN; HUMANIN GF6A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL CULTURE; CELL ISOLATION; CELL METABOLISM; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE METABOLISM; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

DIABETES; HYPERGLYCEMIC CLAMPS; PANCREATIC ISLETS;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KATP CHANNELS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LEPTIN;

EID: 84890544217     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-231092     Document Type: Article

References (50)

1. Hashimoto, Y., Niikura, T., Tajima, H., Yasukawa, T., Sudo, H., Ito, Y., Kita, Y., Kawasumi, M., Kouyama, K., Doyu, M., Sobue, G., Koide, T., Tsuji, S., Lang, J., Kurokawa, K., and Nishimoto, I. (2001) A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc. Natl. Acad. Sci. U. S. A. 98, 6336-6341
2. Tinoco, A. D., and Saghatelian, A. (2011) Investigating endogenous peptides and peptidases using peptidomics. Biochemistry 50, 7447-7461
3. Maximov, V., Martynenko, A., Hunsmann, G., and Tarantul, V. (2002) Mitochondrial 16S rRNA gene encodes a functional peptide, a potential drug for Alzheimer's disease and target for cancer therapy. Med. Hypotheses 59, 670-673
4. Yamagishi, Y., Hashimoto, Y., Niikura, T., and Nishimoto, I. (2003) Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer's disease-relevant insults. Peptides 24, 585-595
5. Le, Y., Gong, W., Tiffany, H. L., Tumanov, A., Nedospasov, S., Shen, W., Dunlop, N. M., Gao, J. L., Murphy, P. M., Oppenheim, J. J., and Wang, J. M. (2001) Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21, RC123
6. Harada, M., Habata, Y., Hosoya, M., Nishi, K., Fujii, R., Kobayashi, M., and Hinuma, S. (2004) N-Formylated humanin activates both formyl peptide receptor-like 1 and 2. Biochem. Biophys. Res. Commun. 324, 255-261
7. Hashimoto, Y., Kurita, M., Aiso, S., Nishimoto, I., and Matsuoka, M. (2009) Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130. Mol. Biol. Cell 20, 2864-2873
8. Ikonen, M., Liu, B., Hashimoto, Y., Ma, L., Lee, K. W., Niikura, T., Nishimoto, I., and Cohen, P. (2003) Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 100, 13042-13047
9. Hashimoto, Y., Suzuki, H., Aiso, S., Niikura, T., Nishimoto, I., and Matsuoka, M. (2005) Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection. Life Sci. 77, 3092-3104
10. Hashimoto, Y., Tsuji, O., Niikura, T., Yamagishi, Y., Ishizaka, M., Kawasumi, M., Chiba, T., Kanekura, K., Yamada, M., Tsukamoto, E., Kouyama, K., Terashita, K., Aiso, S., Lin, A., and Nishimoto, I. (2003) Involvement of c-Jun N-terminal kinase in amyloid precursor protein-mediated neuronal cell death. J. Neurochem. 84, 864-877
11. Niikura, T., Tajima, H., and Kita, Y. (2006) Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin. Curr. Neuropharmacol. 4, 139-147
12. Muzumdar, R. H., Huffman, D. M., Atzmon, G., Buettner, C., Cobb, L. J., Fishman, S., Budagov, T., Cui, L., Einstein, F. H., Poduval, A., Hwang, D., Barzilai, N., and Cohen, P. (2009) Humanin: a novel central regulator of peripheral insulin action. PLoS One 4, e6334
13. Tajima, H., Niikura, T., Hashimoto, Y., Ito, Y., Kita, Y., Terashita, K., Yamazaki, K., Koto, A., Aiso, S., and Nishimoto, I. (2002) Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Neurosci. Lett. 324, 227-231
14. Muzumdar, R. H., Huffman, D. M., Calvert, J. W., Jha, S., Weinberg, Y., Cui, L., Nemkal, A., Atzmon, G., Klein, L., Gundewar, S., Ji, S. Y., Lavu, M., Predmore, B. L., and Lefer, D. J. (2010) Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in mice. Arterioscler. Thromb. Vasc. Biol. 30, 1940-1948
15. Jung, S. S., and Van Nostrand, W. E. (2003) Humanin rescues human cerebrovascular smooth muscle cells from Abeta-induced toxicity. J. Neurochem. 84, 266-272
16. Terashita, K., Hashimoto, Y., Niikura, T., Tajima, H., Yamagishi, Y., Ishizaka, M., Kawasumi, M., Chiba, T., Kanekura, K., Yamada, M., Nawa, M., Kita, Y., Aiso, S., and Nishimoto, I. (2003) Two serine residues distinctly regulate the rescue function of Humanin, an inhibiting factor of Alzheimer's disease-related neurotoxicity: functional potentiation by isomerization and dimerization. J. Neurochem. 85, 1521-1538
17. Arakawa, T., Hirano, A., Shiraki, K., Niikura, T., and Kita, Y. (2011) Advances in characterization of neuroprotective peptide, humanin. Curr. Med. Chem. 18, 5554-5563
18. Hashimoto, Y., Terashita, K., Niikura, T., Yamagishi, Y., Ishizaka, M., Kanekura, K., Chiba, T., Yamada, M., Kita, Y., Aiso, S., Matsuoka, M., and Nishimoto, I. (2004) Humanin antagonists: mutants that interfere with dimerization inhibit neuroprotection by Humanin. Eur. J. Neurosci. 19, 2356-2364
19. Xu, X., Chua, C. C., Gao, J., Hamdy, R. C., and Chua, B. H. (2006) Humanin is a novel neuroprotective agent against stroke. Stroke 37, 2613-2619
20. Arakawa, T., Niikura, T., Tajima, H., and Kita, Y. (2006) The secondary structure analysis of a potent Ser14Gly analog of antiAlzheimer peptide, Humanin, by circular dichroism. J. Pept. Sci. 12, 639-642
21. Tajima, H., Kawasumi, M., Chiba, T., Yamada, M., Yamashita, K., Nawa, M., Kita, Y., Kouyama, K., Aiso, S., Matsuoka, M., Niikura, T., and Nishimoto, I. (2005) A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice. J. Neurosci. Res. 79, 714-723
22. Sponne, I., Fifre, A., Koziel, V., Kriem, B., Oster, T., and Pillot, T. (2004) Humanin rescues cortical neurons from prion-peptide-induced apoptosis. Mol. Cell. Neurosci. 25, 95-102
23. Mamiya, T., and Ukai, M. (2001) [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br. J. Pharmacol. 134, 1597-1599
24. Hoang, P. T., Park, P., Cobb, L. J., Paharkova-Vatchkova, V., Hakimi, M., Cohen, P., and Lee, K. W. (2010) The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice. Metabolism 59, 343-349
25. Kinasiewicz, A., Juszczak, M., Pachecka, J., and Fiedor, P. (2004) Pancreatic islets isolation using different protocols with in situ flushing and intraductal collagenase injection. Physiol. Res. 53, 327-333
26. Rhodes, C. J., and Halban, P. A. (1987) Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway. J. Cell Biol. 105, 145-153
27. Davidson, A. L., and Arion, W. J. (1987) Factors underlying significant underestimations of glucokinase activity in crude liver extracts: physiological implications of higher cellular activity. Arch. Biochem. Biophys. 253, 156-167
28. Cheshenko, N., Del Rosario, B., Woda, C., Marcellino, D., Satlin, L. M., and Herold, B. C. (2003) Herpes simplex virus triggers activation of calcium-signaling pathways. J. Cell Biol. 163, 283-293
29. Straub, S. G., and Sharp, G. W. (2002) Glucose-stimulated signaling pathways in biphasic insulin secretion. Diabetes/Metabol Res. Rev. 18, 451-463
30. Henquin, J. C., Ishiyama, N., Nenquin, M., Ravier, M. A., and Jonas, J. C. (2002) Signals and pools underlying biphasic insulin secretion. Diabetes 51(Suppl. 1), S60-S67
31. Efrat, S., Linde, S., Kofod, H., Spector, D., Delannoy, M., Grant, S., Hanahan, D., and Baekkeskov, S. (1988) Beta-cell lines derived from transgenic mice expressing a hybrid insulin geneoncogene. Proc. Nat. Acad. Sci. 85, 9037-9041
32. Fleischer, N., Chen, C., Surana, M., Leiser, M., Rossetti, L., Pralong, W., and Efrat, S. (1998) Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes 47, 1419-1425
33. Jensen, M. V., Joseph, J. W., Ronnebaum, S. M., Burgess, S. C., Sherry, A. D., and Newgard, C. B. (2008) Metabolic cycling in control of glucose-stimulated insulin secretion. Am. J. Physiol. Endocrinol. Metab. 295, E1287-1297
34. Prentki, M. (1996) New insights into pancreatic beta-cell metabolic signaling in insulin secretion. Eur. J. Endocrinol. 134, 272-286
35. Eto, K., Tsubamoto, Y., Terauchi, Y., Sugiyama, T., Kishimoto, T., Takahashi, N., Yamauchi, N., Kubota, N., Murayama, S., Aizawa, T., Akanuma, Y., Aizawa, S., Kasai, H., Yazaki, Y., and Kadowaki, T. (1999) Role of NADH shuttle system in glucoseinduced activation of mitochondrial metabolism and insulin secretion. Science 283, 981-985
36. Cunningham, B. A., Richard, A. M., Dillon, J. S., Daley, J. T., Civelek, V. N., Deeney, J. T., Yaney, G. C., Corkey, B. E., and Tornheim, K. (2003) Glucagon-like peptide 1 and fatty acids amplify pulsatile insulin secretion from perifused rat islets. Biochem. J. 369, 173-178
37. Yoshida, S., Ohishi, T., Matsui, T., Tanaka, H., Oshima, H., Yonetoku, Y., and Shibasaki, M. (2010) Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. Biochem. Biophys. Res. Commun. 402, 280-285
38. Matschinsky, F. M. (1996) Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45, 223-241
39. Gong, Z., and Muzumdar, R. H. (2012) Pancreatic function, type 2 diabetes, and metabolism in aging. Int. J. Endocrinol. 2012, 320482
40. Doliba, N. M., Qin, W., Najafi, H., Liu, C., Buettger, C. W., Sotiris, J., Collins, H. W., Li, C., Stanley, C. A., Wilson, D. F., Grimsby, J., Sarabu, R., Naji, A., and Matschinsky, F. M. (2012) Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics. Am. J. Physiol. Endocrinol. Metab. 302, E87-E102
41. Froguel, P., Vaxillaire, M., Sun, F., Velho, G., Zouali, H., Butel, M. O., Lesage, S., Vionnet, N., Clement, K., Fougerousse, F., Tanizawa, Y., Weissenbach, J., Beckmann, J. S., Lathrop, G. M., Passa, P., Permutt, M. A., and Cohen, D. (1992) Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulindependent diabetes mellitus. Nature 356, 162-164
42. Vionnet, N., Stoffel, M., Takeda, J., Yasuda, K., Bell, G. I., Zouali, H., Lesage, S., Velho, G., Iris, F., Passa, P., Froguel, P., and Cohen, D. (1992) Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356, 721-722
43. Terauchi, Y., Sakura, H., Yasuda, K., Iwamoto, K., Takahashi, N., Ito, K., Kasai, H., Suzuki, H., Ueda, O., Kamada, N., Jishage, K., Komeda, K., Noda, M., Kanazawa, Y., Taniguchi, S., Miwa, I., Akanuma, Y., Kodama, T., Yazaki, Y., and Kadowaki, T. (1995) Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J. Biol. Chem. 270, 30253-30256
44. Cline, G. W. (2011) Fuel-stimulated insulin secretion depends upon mitochondria activation and the integration of mitochondrial and cytosolic substrate cycles. Diabetes Metab. J. 35, 458-465
45. Eto, K., Suga, S., Wakui, M., Tsubamoto, Y., Terauchi, Y., Taka, J., Aizawa, S., Noda, M., Kimura, S., Kasai, H., and Kadowaki, T. (1999) NADH shuttle system regulates K(ATP) channel-dependent pathway and steps distal to cytosolic Ca(2+) concentration elevation in glucose-induced insulin secretion. J. Biol. Chem. 274, 25386-25392
46. Ishihara, H., Nakazaki, M., Kanegae, Y., Inukai, K., Asano, T., Katagiri, H., Yazaki, Y., Kikuchi, M., Miyazaki, J., Saito, I., and Oka, Y. (1996) Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes 45, 1238-1244
47. MacDonald, M. J., and Marshall, L. K. (2000) Mouse lacking NAD-linked glycerol phosphate dehydrogenase has normal pancreatic beta cell function but abnormal metabolite pattern in skeletal muscle. Arch. Biochem. Biophys. 384, 143-153
48. Nurse, P. (2003) Systems biology: understanding cells. Nature 424, 883
49. Vidal, M., Cusick, M. E., and Barabasi, A. L. (2011) Interactome networks and human disease. Cell 144, 986-998
50. Matschinsky, F. M., Zelent, B., Doliba, N. M., Kaestner, K. H., Vanderkooi, J. M., Grimsby, J., Berthel, S. J., and Sarabu, R. (2011) Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects. Handb. Exp. Pharmacol. 203, 357-401